Clarivate PLC (NYSE:CLVT) Receives $4.83 Average Target Price from Brokerages

Shares of Clarivate PLC (NYSE:CLVT) have been assigned an average recommendation of “Reduce” from the six brokerages that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating and four have given a hold rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $4.8333.

Several equities research analysts have recently issued reports on CLVT shares. Wall Street Zen cut Clarivate from a “buy” rating to a “hold” rating in a report on Saturday, June 21st. Jefferies Financial Group started coverage on Clarivate in a report on Friday, July 18th. They set a “hold” rating and a $4.50 price objective on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Clarivate in a report on Saturday, September 27th. Finally, Wolfe Research started coverage on Clarivate in a report on Wednesday, September 3rd. They set a “peer perform” rating on the stock.

Clarivate Price Performance

Shares of NYSE:CLVT opened at $3.89 on Friday. The business’s fifty day moving average price is $4.12 and its two-hundred day moving average price is $4.10. The stock has a market cap of $2.61 billion, a PE ratio of -6.27 and a beta of 1.44. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.91 and a current ratio of 0.91. Clarivate has a one year low of $3.04 and a one year high of $7.02.

Clarivate (NYSE:CLVT) last announced its earnings results on Wednesday, July 30th. The company reported $0.18 EPS for the quarter, meeting analysts’ consensus estimates of $0.18. The firm had revenue of $621.40 million for the quarter, compared to analysts’ expectations of $587.17 million. Clarivate had a positive return on equity of 8.65% and a negative net margin of 17.33%.Clarivate’s quarterly revenue was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.20 EPS. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. On average, analysts forecast that Clarivate will post 0.63 EPS for the current fiscal year.

Institutional Investors Weigh In On Clarivate

Several hedge funds have recently made changes to their positions in the business. State of Wyoming raised its position in shares of Clarivate by 21.3% in the 2nd quarter. State of Wyoming now owns 68,921 shares of the company’s stock worth $296,000 after buying an additional 12,125 shares during the period. Pitcairn Co. purchased a new position in shares of Clarivate in the 2nd quarter worth $52,000. Tower Research Capital LLC TRC raised its position in shares of Clarivate by 165.6% in the 2nd quarter. Tower Research Capital LLC TRC now owns 17,383 shares of the company’s stock worth $75,000 after buying an additional 10,839 shares during the period. SkyView Investment Advisors LLC raised its position in shares of Clarivate by 4.3% in the 2nd quarter. SkyView Investment Advisors LLC now owns 396,566 shares of the company’s stock worth $1,709,000 after buying an additional 16,227 shares during the period. Finally, Man Group plc raised its position in shares of Clarivate by 228.1% in the 2nd quarter. Man Group plc now owns 3,091,139 shares of the company’s stock worth $13,292,000 after buying an additional 2,148,943 shares during the period. Institutional investors and hedge funds own 85.72% of the company’s stock.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.